Australia has secured two “breakthrough treatments” for Covid-19, with the first shipment arriving within a few weeks.
Over 500,000 additional Covid-19 treatments have been secured for Australians, with the first 5,000 expected to arrive by the end of the month.
The federal government announced on Sunday that it has secured a 500,000 course of treatment for Pfizer’s Covid-19 oral antiviral drug, which is used in combination with the protease inhibitor ritonavir.
Another 15,000 dose of Covid-19 antibody-based therapy Ronapreve was also secured.
Early studies have shown that the drug Ronapreb reduces the risk of hospitalization and death by up to 70% in Covid-positive cases.
Health Minister Greg Hunt said the first shipment of 5,000 shipments is expected to be ready by the end of the month.
The supply is retained in the national medical stockpile.
Pfizer’s antivirals are still in clinical trials, but Hunt is expected to help reduce the severity and incidence of Covid-19-infected and infected adults. Said.
He said it is expected to be available in 2022, subject to final clinical trials and approval by the Therapeutic Product Manager (TGA).
“This oral antiviral treatment is given every 12 hours for 5 days and is designed to block the enzymes that the virus needs to grow early in its life cycle,” Hunt said.
“Co-administration with low doses of ritonavir is expected to help slow the metabolism of treatment in order to maintain activity in the body at high concentrations for long periods of time to fight the virus.”
He said it is expected to be targeted for use in unvaccinated people at risk of developing severe illness.
Australia has also signed a pre-purchase agreement for 300,000 courses of the oral Covid-19 treatment molnupiravir. It will be available in 2022 subject to TGA approval.
Initially published as follows Australia secures two new “breakthrough” Covid treatments
Coronavirus Australia: Federal Government Secures Thousands of Additional Covid-19 Treatments
Source link Coronavirus Australia: Federal Government Secures Thousands of Additional Covid-19 Treatments